Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Industry Trends Analysis Report By Modality (Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging), By Country and Growth Forecast, 2022 - 2

Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Industry Trends Analysis Report By Modality (Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging), By Country and Growth Forecast, 2022 - 2028

The Europe Coronary Heart Disease Diagnostic Imaging Devices Market would witness market growth of 6.3% CAGR during the forecast period (2022-2028).

CAD is the most common type of heart disease, according to the Centers for Disease Control and Prevention (CDC). According to the Centers for Disease Control and Prevention (CDC), a significant proportion of the worldwide population dies from coronary artery disease every year. According to the American Heart Association (AHA), coronary artery disease kills the majority of those in their geriatric age.

The rising prevalence of coronary artery disease is driving the coronary artery imaging market. Coronary artery disease is a leading cause of death in various countries. The market for coronary artery imaging handles issues, such as diagnosis. In these fields, there is a great demand for high resolution, label-free, rapid, and in vivo imaging techniques. The market for coronary artery imaging is expected to grow due to rising rates of coronary artery disease and a geriatric population. Moreover, the market is also estimated to rise due to the increasing demand for CT and MRI.

In the European Union, cardiovascular disorders are the major cause of death. They refer to a wide range of medical conditions that affect the circulatory system (heart and blood vessels) and are frequently caused by atherosclerosis, which is the abnormal build-up of plaque (which can include cholesterol or fatty substances) on the interior walls of a person's arteries. Ischemic heart disease (heart attacks), as well as cerebrovascular illnesses, is two of the most frequent circulatory system diseases (strokes). Moreover, several EU Member States have witnessed a decrease in the number of deaths related to circulatory system disorders in recent years. These changes could have occurred, at least in part, as a result of enhanced screening and novel surgical methods, as well as new types of medication and patient lifestyle modifications.

The Germany market dominated the Europe Coronary Heart Disease Diagnostic Imaging Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $147.2 Million by 2028. The UK market is estimated to grow at a CAGR of 5.4% during (2022 - 2028). Additionally, The France market would witness a CAGR of 7.1% during (2022 - 2028).

Based on Modality, the market is segmented into Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).

Scope of the Study

Market Segments covered in the Report:

By Modality

• Nuclear Medicine
• Computed Tomography
• Ultrasound
• X rays
• Magnetic Resonance Imaging

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

• General Electric (GE) Co. (GE Healthcare)
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Canon, Inc. (Canon Medical Systems Corporation)
• Mindray Medical International Limited
• Chison Medical Technologies Co., Ltd.
• Analogic Corporation (Altaris Capital Partners)

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free